<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Med MicrobiolCan J Infect Dis Med MicrobiolPGIThe Canadian Journal of" exact="Infectious" post="Diseases &amp;amp; Medical Microbiology1712-95321918-1493Pulsus Group Inc pmcid: 4353273idmm-26-e1 :"/>
 <result pre="MicrobiolCan J Infect Dis Med MicrobiolPGIThe Canadian Journal of Infectious" exact="Diseases" post="&amp;amp; Medical Microbiology1712-95321918-1493Pulsus Group Inc pmcid: 4353273idmm-26-e1 : AMMI"/>
 <result pre="concept was then approved by Association of Medical Microbiology and" exact="Infectious" post="Disease (AMMI) Canada. A first draft was cowritten by"/>
 <result pre="was then approved by Association of Medical Microbiology and Infectious" exact="Disease" post="(AMMI) Canada. A first draft was cowritten by all"/>
 <result pre="further review from the AMMI Canada Guidelines Committee and the" exact="Infectious" post="Diseases and Immunization Committee of the Canadian Paediatric Society."/>
 <result pre="review from the AMMI Canada Guidelines Committee and the Infectious" exact="Diseases" post="and Immunization Committee of the Canadian Paediatric Society. AMMI"/>
 <result pre="seasons of H3N2 vaccine mismatch, VE estimates of 40% or" exact="lower" post="have been found in association with a comparable or"/>
 <result pre="circulating, with nomenclature as described by the European Centre for" exact="Disease" post="Prevention and Control (ECDC) in its periodic surveillance reports"/>
 <result pre="European Centre for Disease Prevention and Control (ECDC) in its" exact="periodic" post="surveillance reports (18,19). Among 480 global H3 gene sequences"/>
 <result pre="hemisphere vaccine (5) (verbal communication, D Skowronski, BC Centre for" exact="Disease" post="Control). Viruses belonging to phylogenetic subgroups 3C.3, 3C.3a and"/>
 <result pre="British Columbia, Canada (verbal communication, D. Skowronski, BC Centre for" exact="Disease" post="Control). The emerging subgroups 3C.2a and 3C.3x H3N2 variants"/>
 <result pre="other staff, influenza immunizations rates are more variable but generally" exact="lower" post="than in residents. Influenza outbreaks among residents are not"/>
 <result pre="identify the cause of ILI Promotion of, and adherence to," exact="infection" post="control guidelines and practices including respiratory etiquette and routine"/>
 <result pre="of, and adherence to, infection control guidelines and practices including" exact="respiratory" post="etiquette and routine practices, and the use of personal"/>
 <result pre="and an interim guideline from the United States Centers for" exact="Disease" post="Control and Prevention (22). For control of an outbreak"/>
 <result pre="critical for early identification and response. FluWatch defines ILI as" exact="acute" post="onset of respiratory illness with fever and cough and"/>
 <result pre="identification and response. FluWatch defines ILI as acute onset of" exact="respiratory" post="illness with fever and cough and with one or"/>
 <result pre="order of declining preference: RT-PCR, rapid influenza diagnostic tests and" exact="viral" post="culture. For surveillance purposes, FluWatch defines an influenza outbreak"/>
 <result pre="authority/Medical Officer of Health, in consultation with health care and" exact="infection" post="control practitioners, to declare an influenza outbreak in a"/>
 <result pre="to treat and prevent influenza in residents, together with other" exact="infection" post="control measures, are important for the control of influenza"/>
 <result pre="more than 40 kg. Clinicians are advised to consult an" exact="infectious diseases" post="clinician or pharmacist for dosing of premature infants in"/>
 <result pre="illness, which may be due to the current virus, another" exact="viral" post="agent or an oseltamivir- (or zanamavir)-resistant influenza virus. Expert"/>
 <result pre="document by the Public Health Agency of Canada and the" exact="Infectious" post="Diseases and Immunization Committee of the Canadian Paediatric Society"/>
 <result pre="by the Public Health Agency of Canada and the Infectious" exact="Diseases" post="and Immunization Committee of the Canadian Paediatric Society and"/>
 <result pre="in Canada, 1992–2009PLoS ONE20138e8048124312225 2.ThompsonWWShayDKWeintraubEet al.Mortality associated with influenza and" exact="respiratory" post="syncytial virus in the United StatesJAMA20032891798612517228 3.ThompsonWWShayDKWeintraubEet al.Influenza-associated hospitalizations"/>
 <result pre="of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in" exact="primary" post="care in the United Kingdom: 2012/13 end of season"/>
 <result pre="typeJ Infect Dis20141118[Epub ahead of print] 18.collab: European Centre for" exact="Disease" post="Prevention and Control (ECDC)Surveillance report: Influenza virus characterizationSummary Europe92014&amp;lt;www.ecdc.europa.eu/en/publications/Publications/Influenza-ERLI-Net-report-Sept-2014.pdf&amp;gt;"/>
 <result pre="characterizationSummary Europe92014&amp;lt;www.ecdc.europa.eu/en/publications/Publications/Influenza-ERLI-Net-report-Sept-2014.pdf&amp;gt; (Accessed December 19, 2015). 19.collab: European Centre for" exact="Disease" post="Prevention and Control (ECDC)Surveillance report: Influenza virus characterizationSummary Europe112014&amp;lt;www.ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&amp;amp;ID=1235&amp;gt;"/>
 <result pre="seasonal influenza vaccine for 2014–2015 22.collab: United States Centers for" exact="Disease" post="Control &amp;amp; PreventionInterim guidance for influenza outbreak management in"/>
</results>
